IVAX Corporation, Miami
David Malina, 305-575-6043
Director/Investor Relations & Corporate Communications

IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced that the U.S. District Court in
Washington D.C. has extended its temporary restraining order against the United
States Food and Drug Administration ("FDA") in the Metformin ER case for three
more business days, ending at the close of business on Wednesday, November 26,
2003.

IVAX Corporation, headquartered in Miami, Florida, discovers, develops,
manufactures, and markets branded and brand equivalent (generic) pharmaceuticals
and veterinary products in the U.S. and internationally.

Copies of this and other news releases may be obtained free of charge from IVAX'
website at http://www.ivax.com.